Brisbane biotech Gelomics will signify Australia in KPMG’s International Tech Innovator problem after successful the native pitch competitors.
The startup, which grows human tissue in a petri dish for drug testing as a substitute for animal testing in pharmaceutical drug improvement, was chosen from amongst 5 high-powered finalists chosen from 155 entries.
The annual KPMG International Tech Innovator problem seeks to determine the world’s most modern and thrilling tech startups. The Australian leg of the competitors, organised by KPMG Excessive Progress ventures. Amanda Value, head of KPMG Excessive Progress Ventures mentioned the calibre of candidates was distinctive within the the third yr of the Australian program.
“All of our finalists got here to the desk with daring, industry-changing concepts,” she mentioned.
“Going international is an crucial and a problem for Australia startups. The KPMG Tech Innovator initiative helps put founders on the map by showcasing their innovation on the largest tech convention on this planet.
“We had been delighted with the breadth and depth of Australian innovation we noticed in the course of the course of to pick these finalists. Every entry was distinctive and demonstrated a excessive degree of worldwide potential, making the choice course of extremely difficult.”
Gelomics cofounder and CEO Dr Christoph Meinert receives a fully-funded journey to Lisbon’s Internet Summit current their thought with an opportunity to be named the 2024 KPMG International Tech Innovator.
He’ll even have the possibility to current their expertise in entrance of 70,000 traders, coverage makers and {industry} leaders at one of many world’s largest startup and expertise conferences.
Final month Gelomics raised its first enterprise capital, banking $2.2 million in a pre-Seed spherical.
The finalists had been judged by KPMG Enterprise’s Josh Geelan, Fundamental Sequence’s Emerald Scofield, Jerry Stesel from OIF, Lighter Capital’s, Melissa Widner, and Chris Gillings from Minimize By means of Enterprise.
The ultimate 5 had been:
DoveTail Electrical
CEO & cofounder: David Doral
DoveTail Electrical offers an built-in electrical system that features electrical motors and battery packs to show current airframes into zero-emission industrial plane for brief flights. This permits shoppers to get modified plane for regional flight, integrating hydrogen methods and aviation operators to avail the service for a financially sustainable future.
Jim Fader, from Eden Brew
Eden Brew
Cofounder & CEO: Jim Fader
Eden Brew makes use of precision fermentation to brew nature-identical casein (dairy) proteins.
These caseins are then mixed within the presence of diet, to kind the casein micelle, the identical as in dairy milk.
The micelle is key for nutrient loading and bioavailability, warmth stability, and lots of the sensory and bodily properties liked by shoppers in dairy milk & dairy client merchandise.
Gelomics
CEO: Christoph Meinert
Gelomics revolutionises drug improvement by enabling pharmaceutical firms to develop human tissue in a petri dish. This disruptive innovation serves as a extremely predictive various to animal experiments and standard cell cultures, which generally fail to foretell human drug responses precisely.
The expertise will considerably cut back the reliance on animal testing, speed up drug improvement, reduce prices, and allow life-saving therapies to achieve sufferers faster and safer than earlier than.
InTruth Applied sciences
CEO & founder: Nicole Gibson
InTruth Applied sciences is a developer of a wearable-compatible app that tracks your emotional state in real-time, and offers hyper personalised AI insights, performing as a private emotion coach and decision-making instrument.
Sustainable Salons
Cofounder: Paul Frasca
Sustainable Salons companions with salons to gather and repurpose waste supplies like hair, metals, plastics, and chemical substances.
These supplies are reworked into invaluable sources, akin to hair booms for oil spills, soil therapies for crops, and plastic for closed-loop merchandise.
NOW READ: Brisbane to the world: How biotech game-changer Gelomics expanded to 21+ international locations in 5 years